BE876297A - Nouveaux derives de 4-amino-2-piperidino-quinazoline, leur procede de production et medicament les contenant - Google Patents

Nouveaux derives de 4-amino-2-piperidino-quinazoline, leur procede de production et medicament les contenant

Info

Publication number
BE876297A
BE876297A BE0/195197A BE195197A BE876297A BE 876297 A BE876297 A BE 876297A BE 0/195197 A BE0/195197 A BE 0/195197A BE 195197 A BE195197 A BE 195197A BE 876297 A BE876297 A BE 876297A
Authority
BE
Belgium
Prior art keywords
piperidino
quinazoline
amino
production process
product containing
Prior art date
Application number
BE0/195197A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BE876297A publication Critical patent/BE876297A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BE0/195197A 1978-05-18 1979-05-16 Nouveaux derives de 4-amino-2-piperidino-quinazoline, leur procede de production et medicament les contenant BE876297A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2035178 1978-05-18

Publications (1)

Publication Number Publication Date
BE876297A true BE876297A (fr) 1979-11-16

Family

ID=10144517

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/195197A BE876297A (fr) 1978-05-18 1979-05-16 Nouveaux derives de 4-amino-2-piperidino-quinazoline, leur procede de production et medicament les contenant

Country Status (30)

Country Link
US (1) US4243666A (fr)
JP (1) JPS554370A (fr)
AR (2) AR223487A1 (fr)
AT (1) ATA363379A (fr)
AU (1) AU512947B2 (fr)
BE (1) BE876297A (fr)
CA (1) CA1240325A (fr)
CH (1) CH643553A5 (fr)
CS (1) CS214796B2 (fr)
DD (1) DD143613A5 (fr)
DE (1) DE2919800A1 (fr)
DK (1) DK159079A (fr)
ES (2) ES480671A1 (fr)
FI (1) FI64589C (fr)
FR (1) FR2434162A1 (fr)
GR (1) GR72824B (fr)
HU (1) HU182562B (fr)
IL (1) IL57297A (fr)
IN (1) IN153045B (fr)
IT (1) IT1114222B (fr)
LU (1) LU81284A1 (fr)
NL (1) NL172157C (fr)
NO (1) NO791648L (fr)
NZ (1) NZ190465A (fr)
PH (1) PH14802A (fr)
PL (2) PL120651B1 (fr)
PT (1) PT69622A (fr)
SE (1) SE439306B (fr)
YU (2) YU115279A (fr)
ZA (1) ZA792390B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4607034A (en) * 1979-10-29 1986-08-19 Mitsubishi Yuka Pharmaceutical Co., Ltd. Quinazoline derivatives and pharmaceutical composition thereof
JPS5962766U (ja) * 1982-06-30 1984-04-25 守田　智 小動物用給水器
GB8414518D0 (en) * 1984-06-07 1984-07-11 Pfizer Ltd Therapeutic agents
US5801195A (en) * 1994-12-30 1998-09-01 Celgene Corporation Immunotherapeutic aryl amides
US6248888B1 (en) 1997-11-14 2001-06-19 Teva Pharmaceutical Industries Ltd. Process for the preparation of terazosin hydrochloride dihydrate
KR20030069218A (ko) * 2001-01-18 2003-08-25 다케다 야쿠힌 고교 가부시키가이샤 벤질피페리딘 화합물의 제조 방법
US6746460B2 (en) * 2002-08-07 2004-06-08 Satiety, Inc. Intra-gastric fastening devices
BRPI0415683A (pt) * 2003-11-03 2006-12-19 Warner Lambert Co inibidores da reabsorção de norepinefrina para o tratamento de distúrbios do sistema nervoso central
WO2008045564A2 (fr) * 2006-10-12 2008-04-17 Epix Delaware, Inc. Composés de carboxamide et leur utilisation
KR101441930B1 (ko) * 2007-04-04 2014-09-19 시플라 리미티드 에르로티닙 및 그의 약학적으로 허용가능한 염의 제조방법
CN101925383A (zh) 2007-12-11 2010-12-22 赛特帕斯凡德株式会社 甲酰胺化合物及其作为趋化因子受体激动剂的应用
CA2737587C (fr) * 2008-11-14 2016-08-09 F. Hoffmann-La Roche Ag Derives de quinazoline comme antagonistes des recepteurs nk3

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
FR2321890A1 (fr) * 1975-08-26 1977-03-25 Synthelabo Nouveaux derives de la quinazoline, leurs sels, leur preparation et les medicaments qui en renferment
DK140695C (da) * 1976-05-07 1980-05-12 Synthelabo Analogifremgangsmaade til fremstilling af 2,4-diamino-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf

Also Published As

Publication number Publication date
GR72824B (fr) 1983-12-06
AU4710179A (en) 1979-11-22
PT69622A (en) 1979-06-01
AR223487A1 (es) 1981-08-31
PH14802A (en) 1981-12-14
CS214796B2 (en) 1982-05-28
IN153045B (fr) 1984-05-26
ES8101584A1 (es) 1980-12-16
HU182562B (en) 1984-02-28
CH643553A5 (de) 1984-06-15
AU512947B2 (en) 1980-11-06
DD143613A5 (de) 1980-09-03
FI64589B (fi) 1983-08-31
NZ190465A (en) 1981-05-01
LU81284A1 (fr) 1980-12-16
ATA363379A (de) 1983-05-15
IL57297A0 (en) 1979-09-30
FR2434162B1 (fr) 1983-04-22
FR2434162A1 (fr) 1980-03-21
YU256382A (en) 1983-04-30
JPS5623992B2 (fr) 1981-06-03
CA1240325A (fr) 1988-08-09
IT7922720A0 (it) 1979-05-16
DK159079A (da) 1979-11-19
NO791648L (no) 1979-11-20
SE7904358L (sv) 1979-11-19
NL7903853A (nl) 1979-11-20
FI791562A (fi) 1979-11-19
US4243666A (en) 1981-01-06
ES480671A1 (es) 1980-08-16
YU115279A (en) 1983-04-30
PL120651B1 (en) 1982-03-31
PL121158B1 (en) 1982-04-30
AR224784A1 (es) 1982-01-15
JPS554370A (en) 1980-01-12
FI64589C (fi) 1983-12-12
PL215626A1 (fr) 1980-08-25
PL223844A1 (fr) 1981-01-02
ZA792390B (en) 1980-07-30
ES488210A0 (es) 1980-12-16
NL172157B (nl) 1983-02-16
IL57297A (en) 1983-02-23
DE2919800A1 (de) 1979-11-22
IT1114222B (it) 1986-01-27
SE439306B (sv) 1985-06-10
NL172157C (nl) 1983-07-18

Similar Documents

Publication Publication Date Title
FR2293928A1 (fr) Nouveaux derives d'acide 3-amino-indazolecarboxylique, leur procede de preparation et medicament les contenant
BE874135A (fr) Nouveaux analogues de prostacycline, leur procede de production et medicament les contenant
FR2297037A1 (fr) Nouveaux derives de biphenyloxy, medicaments les contenant et procede pour leur preparation
BE855713Q (fr) Nouveaux derives de 4-aminoquinoleine, leur procede de preparation et medicament les contenant
FR2344531A1 (fr) Nouveaux derives de l'acide sulfonamidobenzoique, leur procede de preparation et medicaments les contenant
BE876297A (fr) Nouveaux derives de 4-amino-2-piperidino-quinazoline, leur procede de production et medicament les contenant
BE868943A (fr) Nouveaux 3-indolyl-tertiobutylaminopropanols, leur procede de production et medicament les contenant
FR2338938A1 (fr) Nouveaux derives de la piperazine et de ses homologues, leur procede de preparation et medicament les contenant
BE875247A (fr) Nouveaux antibiotiques du type beta-lactame, leur procede de production et medicament les contenant
BE829417A (fr) Nouveaux pyrimidinols, leur procede de preparation et medicament les contenant
BE862278A (fr) Nouveaux composes heterocycliques, leur procede de preparation et medicament les contenant
FR2290897A1 (fr) Nouveaux derives d'aminopropanol, leur procede de preparation et des medicaments les contenant
BE858781A (fr) Nouveaux derives 1,4-dihydropyridiques de sucres, leur procede de preparation et medicament les contenant
FR2292477A1 (fr) Derives de 1-amidoalkyl-4-sulfonyl-piperazine, leur procede d'obtention et medicaments contenant lesdits derives
BE864644A (fr) Nouveaux derives de prostaglandines, leur procede de preparation et medicaments les contenant
BE860709A (fr) Nouveaux derives substitues de 0-phenylenediamine, leur procede de preparation et medicament les contenant
LU79007A1 (fr) Nouveaux derives semi-synthetiques de 4"-amino-oleandomycine,leur procede de preparation et medicament les contenant
BE859949A (fr) Nouveaux derives thiazoliques leur procede de preparation et medicament antherminthique les contenant
FR2274288A1 (fr) Nouveaux composes arylsulfonylcarbamoyl-1,3-dicarbonyliques, leur procede de preparation et medicament les contenant
BE843341A (fr) Nouvelles penicillines, leur procede de preparation et medicament les contenant
FR2292474A1 (fr) Nouveaux diaryloxy-imidazolyl-o,n-acetals, leur procede de preparation et medicament les contenant
BE884291A (fr) Derives de tallysomycine, leur procede de production et medicament les contenant
BE861687A (fr) Nouveaux dithiosalicylamides porterus de groupes alkyliques basiques, leur procede de preparation et medicament les contenant
BE872023A (fr) Derives de 4-amino-2-piperidinoquinazoline, leur procede de production et composition pharmaceutique les contenant
LU80746A1 (fr) Nouveaux derives 4"-deoxy-4"-arylglyoxamido et aroylthioformamido de l'oleandomycine et leurs esters,leur procede de production et medicament les contenant